FAScinate Therapeutics Inc. Submits Investigational New Drug (IND)...

Company Aims to Evaluate Safety, Tolerability, and Preliminary Efficacy of New Drug Candidate "KM-819"(PRWeb November 02, 2021)Read the full story at https://www.prweb.com/releases/fascinate_therapeutics_inc_submits_investigational_new_drug_ind_application_for_phase_2_clinical_studies_of_company_s_new_parkinson_s_disease_treatment/prweb18301841.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news